JOTROL™
Alzheimer's Disease
Key Facts
About Jupiter Neurosciences
Jupiter Neurosciences is a private, clinical-stage company founded in 2019, developing novel oral therapies targeting neuroinflammation. Its lead platform, JOTROL™, is a patented micellar formulation of resveratrol designed to overcome poor bioavailability and enable therapeutic dosing for central nervous system disorders. The company's strategy involves a dual-path pipeline, with a long-term focus on Alzheimer's disease and parallel development in rare, orphan neurological indications. Jupiter appears to be pre-revenue and is likely funded by private investment as it advances its programs.
View full company profileAbout Jupiter Neurosciences
Jupiter Neurosciences is a private, clinical-stage company founded in 2019, developing novel oral therapies targeting neuroinflammation. Its lead platform, JOTROL™, is a patented micellar formulation of resveratrol designed to overcome poor bioavailability and enable therapeutic dosing for central nervous system disorders. The company's strategy involves a dual-path pipeline, with a long-term focus on Alzheimer's disease and parallel development in rare, orphan neurological indications. Jupiter appears to be pre-revenue and is likely funded by private investment as it advances its programs.
View full company profileTherapeutic Areas
Other Alzheimer's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| NUZ-001 | Neurizon Therapeutics | Preclinical |
| ALZN002 | Alzamend Neuro | Preclinical |
| P021 | Phanes Biotech | Preclinical |
| PB43D | Phanes Biotech | Preclinical |
| UB-311 | Vaxxinity | Phase 2 |
| Lecanemab | BioArctic | Launched |
| BAN2401 | BioArctic | Preclinical |
| Undisclosed Programs | johnson-and-johnson-innovative-medicine | Pipeline |
| MK-6240 (florquinitau) | Lantheus Medical Imaging | Regulatory Filing |
| NAV-4694 (flutafuranol) | Lantheus Medical Imaging | Phase 3 |
| LNTH-2620/PI-2620 | Lantheus Medical Imaging | Phase 3 |
| itMSCs | Stemedica Cell Technologies | Clinical Development |